SE325901B - - Google Patents

Info

Publication number
SE325901B
SE325901B SE01517/65A SE151765A SE325901B SE 325901 B SE325901 B SE 325901B SE 01517/65 A SE01517/65 A SE 01517/65A SE 151765 A SE151765 A SE 151765A SE 325901 B SE325901 B SE 325901B
Authority
SE
Sweden
Application number
SE01517/65A
Inventor
J Schmitt
Original Assignee
Clin Byla Ets
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Clin Byla Ets filed Critical Clin Byla Ets
Publication of SE325901B publication Critical patent/SE325901B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/80Radicals substituted by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SE01517/65A 1964-02-07 1965-02-05 SE325901B (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR963087A FR1408721A (fr) 1964-02-07 1964-02-07 Dérivés du furanne et leur préparation

Publications (1)

Publication Number Publication Date
SE325901B true SE325901B (fr) 1970-07-13

Family

ID=8822720

Family Applications (1)

Application Number Title Priority Date Filing Date
SE01517/65A SE325901B (fr) 1964-02-07 1965-02-05

Country Status (9)

Country Link
US (1) US3355463A (fr)
BE (1) BE659329A (fr)
BR (1) BR6566852D0 (fr)
DE (1) DE1493626B2 (fr)
DK (1) DK114699B (fr)
FR (1) FR1408721A (fr)
GB (1) GB1092695A (fr)
NL (2) NL6501095A (fr)
SE (1) SE325901B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3484457A (en) * 1968-03-15 1969-12-16 Bristol Myers Co Certain spiro butyrolactones
CN1681495B (zh) 2002-08-19 2010-05-12 辉瑞产品公司 用于治疗过度增生性疾病的组合物
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
JP5498168B2 (ja) 2006-12-01 2014-05-21 ブリストル−マイヤーズ スクイブ カンパニー アテローム性動脈硬化および循環器疾患の治療のためのcetp阻害剤としてのn−((3−ベンジル)−2,2−(ビス−フェニル)−プロパン−1−アミン誘導体
EP2986599A1 (fr) 2013-04-17 2016-02-24 Pfizer Inc. Dérivés de n-pipéridin-3-ylbenzamide dans le traitement des maladies cardiovasculaires
WO2016055901A1 (fr) 2014-10-08 2016-04-14 Pfizer Inc. Composés d'amide substitué
BR112021013807A2 (pt) 2019-01-18 2021-11-30 Astrazeneca Ab Inibidores de pcsk9 e seus métodos de uso

Also Published As

Publication number Publication date
FR1408721A (fr) 1965-08-20
BR6566852D0 (pt) 1973-02-22
US3355463A (en) 1967-11-28
NL128190C (fr)
DE1493626A1 (de) 1969-07-17
BE659329A (fr) 1965-08-05
GB1092695A (en) 1967-11-29
DK114699B (da) 1969-07-28
DE1493626B2 (de) 1973-05-30
NL6501095A (fr) 1965-08-09

Similar Documents

Publication Publication Date Title
BE658292A (fr)
AU442366B2 (fr)
BE637777A (fr)
BE642367A (fr)
BE622126A (fr)
BE621510A (fr)
BE613833A (fr)
BE610935A (fr)
BE603534A (fr)
BE584699A (fr)
BE658364A (fr)
BE564626A (fr)
BE554195A (fr)
BE518974A (fr)
BE507097A (fr)
BE483969A (fr)
BE659329A (fr)
BE47396A (fr)
BE432268A (fr)
BE626083A (fr)
BE626684A (fr)
BE627057A (fr)
BE627390A (fr)
BE627931A (fr)
BE628611A (fr)